MedTrace Logo

The Assessment of Antimicrobial Peptides Against Fungal Infection

NCT05368948 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-05-10

No results posted yet for this study

Summary

* Identification of different types of fungi.
* Determine sensitivity the profile and the resistance pattern of the clinical isolates against antifungal.
* Determine the antifungal effects of defensin, cathelicidin and histatins and their effects on biofilm formation and resistant isolates.

Conditions

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • amal mohamad hosni, lecturer · Assiut University

  • asmaa omar ahmed, assistant professor · Assiut University

  • mohamad zakaria abd elrahman, professor · Assiut University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-31
Primary Completion
2023-02-28
Completion
2023-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05368948 on ClinicalTrials.gov